Skip to main content
Top
Published in: Journal of Neurology 2/2017

01-02-2017 | Original Communication

Cardiac parasympathetic dysfunction in the early phase of Parkinson’s disease

Authors: Masashi Suzuki, Tomohiko Nakamura, Masaaki Hirayama, Miki Ueda, Masahisa Katsuno, Gen Sobue

Published in: Journal of Neurology | Issue 2/2017

Login to get access

Abstract

Cardiac parasympathetic function is strongly affected by aging. Although sympathetic dysfunction has been well documented in Parkinson’s disease (PD), cardiac parasympathetic dysfunction has not been well studied. The objective of this study was to clarify the development of cardiac parasympathetic dysfunction in the early phase of PD and to explore the age-corrected correlation between cardiac parasympathetic dysfunction and cardiac sympathetic dysfunction. We reviewed 25 healthy controls and 56 patients with idiopathic PD of Hoehn and Yahr stages I–III. We evaluated cardiac parasympathetic function using the Valsalva ratio, the baroreflex sensitivity (BRS) and the coefficient of variation of RR intervals in the resting state (resting-CVRR) and during deep breathing (DB-CVRR). In addition, we measured cardiac 123I-metaiodobenzylguanidine (MIBG) uptake to investigate the relationship between cardiac sympathetic and parasympathetic dysfunction in PD. Compared with healthy controls, patients with PD showed significantly decreased cardiac parasympathetic parameters (resting-CVRR 2.8 ± 1.3 vs. 1.7 ± 0.6%, p < 0.001; DB-CVRR 5.8 ± 2.3 vs. 3.8 ± 1.7%, p < 0.001; Valsalva ratio 1.52 ± 0.26 vs. 1.34 ± 0.17, p < 0.01; BRS 10.6 ± 9.5 vs. 5.0 ± 5.4 ms/mmHg, p < 0.01). In particular, resting-CVRR and DB-CVRR were significantly decreased in the early phase of PD. In age-corrected analyses, none of the parasympathetic indices correlated with the delayed cardiac 123I-MIBG uptake. These observations indicate that cardiac parasympathetic dysfunction occurs in the early phase of PD, but not necessarily in parallel with cardiac sympathetic dysfunction.
Literature
3.
go back to reference Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211CrossRefPubMed Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211CrossRefPubMed
4.
go back to reference Hamada K, Hirayama M, Watanabe H, Kobayashi R, Ito H, Ieda T, Koike Y, Sobue G (2003) Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson’s disease. J Neurol Neurosurg Psychiatry 74(4):423–426CrossRefPubMedPubMedCentral Hamada K, Hirayama M, Watanabe H, Kobayashi R, Ito H, Ieda T, Koike Y, Sobue G (2003) Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson’s disease. J Neurol Neurosurg Psychiatry 74(4):423–426CrossRefPubMedPubMedCentral
5.
go back to reference Hirayama M, Hakusui S, Koike Y, Ito K, Kato T, Ikeda M, Hasegawa Y, Takahashi A (1995) A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst 53(2–3):230–234CrossRefPubMed Hirayama M, Hakusui S, Koike Y, Ito K, Kato T, Ikeda M, Hasegawa Y, Takahashi A (1995) A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst 53(2–3):230–234CrossRefPubMed
6.
8.
go back to reference Oka H, Toyoda C, Yogo M, Mochio S (2011) Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson’s disease. J Neural Trans (Vienna, Austria : 1996) 118(9):1323–1327. doi:10.1007/s00702-011-0598-5 CrossRef Oka H, Toyoda C, Yogo M, Mochio S (2011) Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson’s disease. J Neural Trans (Vienna, Austria : 1996) 118(9):1323–1327. doi:10.​1007/​s00702-011-0598-5 CrossRef
9.
go back to reference Oka H, Yoshioka M, Morita M, Mochio S, Inoue K (2003) Cardiac sympathetic dysfunction in Parkinson’s disease–relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver. Rinsho Shinkeigaku Clin Neurol 43(8):465–469 Oka H, Yoshioka M, Morita M, Mochio S, Inoue K (2003) Cardiac sympathetic dysfunction in Parkinson’s disease–relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver. Rinsho Shinkeigaku Clin Neurol 43(8):465–469
10.
go back to reference Orimo S, Ozawa E, Oka T, Nakade S, Tsuchiya K, Yoshimoto M, Wakabayashi K, Takahashi H (2001) Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA. Neurology 57(6):1140–1141CrossRefPubMed Orimo S, Ozawa E, Oka T, Nakade S, Tsuchiya K, Yoshimoto M, Wakabayashi K, Takahashi H (2001) Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA. Neurology 57(6):1140–1141CrossRefPubMed
12.
go back to reference Korkushko OV, Shatilo VB, Plachinda YuI, Shatilo TV (1991) Autonomic control of cardiac chronotropic function in man as a function of age: assessment by power spectral analysis of heart rate variability. J Auton Nerv Syst 32(3):191–198CrossRefPubMed Korkushko OV, Shatilo VB, Plachinda YuI, Shatilo TV (1991) Autonomic control of cardiac chronotropic function in man as a function of age: assessment by power spectral analysis of heart rate variability. J Auton Nerv Syst 32(3):191–198CrossRefPubMed
13.
go back to reference Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51(6):745–752CrossRefPubMedPubMedCentral Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51(6):745–752CrossRefPubMedPubMedCentral
14.
go back to reference Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Euro Heart J 17(3):354–381 Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Euro Heart J 17(3):354–381
15.
go back to reference Ewing DJ, Martyn CN, Young RJ, Clarke BF (1985) The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8(5):491–498CrossRefPubMed Ewing DJ, Martyn CN, Young RJ, Clarke BF (1985) The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8(5):491–498CrossRefPubMed
16.
go back to reference Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schols L, Reichmann H, Berg D, Ziemssen T (2009) Valsalva manoeuvre in patients with different Parkinsonian disorders. J Neural Transm (Vienna) 116(7):875–880. doi:10.1007/s00702-009-0239-4 CrossRef Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schols L, Reichmann H, Berg D, Ziemssen T (2009) Valsalva manoeuvre in patients with different Parkinsonian disorders. J Neural Transm (Vienna) 116(7):875–880. doi:10.​1007/​s00702-009-0239-4 CrossRef
17.
go back to reference Wada N, Singer W, Gehrking TL, Sletten DM, Schmelzer JD, Low PA (2014) Comparison of baroreflex sensitivity with a fall and rise in blood pressure induced by the Valsalva manoeuvre. Clinical Sci (London, England: 1979) 127(5):307–313. doi:10.1042/cs20130802 CrossRef Wada N, Singer W, Gehrking TL, Sletten DM, Schmelzer JD, Low PA (2014) Comparison of baroreflex sensitivity with a fall and rise in blood pressure induced by the Valsalva manoeuvre. Clinical Sci (London, England: 1979) 127(5):307–313. doi:10.​1042/​cs20130802 CrossRef
18.
go back to reference Nakamura T, Hirayama M, Hara T, Hama T, Watanabe H, Sobue G (2011) Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson’s disease? Mov Dis Off J Mov Dis Soc 26(10):1869–1874. doi:10.1002/mds.23744 CrossRef Nakamura T, Hirayama M, Hara T, Hama T, Watanabe H, Sobue G (2011) Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson’s disease? Mov Dis Off J Mov Dis Soc 26(10):1869–1874. doi:10.​1002/​mds.​23744 CrossRef
19.
go back to reference Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE (1992) A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 13(7):513–521CrossRefPubMed Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE (1992) A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 13(7):513–521CrossRefPubMed
21.
go back to reference Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz I, Schondorff R, Stewart JM, van Dijk JG (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res Off J Clin Auton Res Soc 21(2):69–72. doi:10.1007/s10286-011-0119-5 CrossRef Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz I, Schondorff R, Stewart JM, van Dijk JG (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res Off J Clin Auton Res Soc 21(2):69–72. doi:10.​1007/​s10286-011-0119-5 CrossRef
22.
go back to reference Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 67(2):189–194CrossRefPubMedPubMedCentral Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 67(2):189–194CrossRefPubMedPubMedCentral
23.
go back to reference Kallio M, Haapaniemi T, Turkka J, Suominen K, Tolonen U, Sotaniemi K, Heikkila VP, Myllyla V (2000) Heart rate variability in patients with untreated Parkinson’s disease. Euro J Neurol Off J Euro Fed Neurol Soc 7(6):667–672 Kallio M, Haapaniemi T, Turkka J, Suominen K, Tolonen U, Sotaniemi K, Heikkila VP, Myllyla V (2000) Heart rate variability in patients with untreated Parkinson’s disease. Euro J Neurol Off J Euro Fed Neurol Soc 7(6):667–672
25.
go back to reference Gjerloff T, Fedorova T, Knudsen K, Munk OL, Nahimi A, Jacobsen S, Danielsen EH, Terkelsen AJ, Hansen J, Pavese N, Brooks DJ, Borghammer P (2015) Imaging acetylcholinesterase density in peripheral organs in Parkinson’s disease with 11C-donepezil PET. Brain J Neurol 138(Pt 3):653–663. doi:10.1093/brain/awu369 CrossRef Gjerloff T, Fedorova T, Knudsen K, Munk OL, Nahimi A, Jacobsen S, Danielsen EH, Terkelsen AJ, Hansen J, Pavese N, Brooks DJ, Borghammer P (2015) Imaging acetylcholinesterase density in peripheral organs in Parkinson’s disease with 11C-donepezil PET. Brain J Neurol 138(Pt 3):653–663. doi:10.​1093/​brain/​awu369 CrossRef
27.
go back to reference Alonso A, Huang X, Mosley TH, Heiss G, Chen H (2015) Heart rate variability and the risk of Parkinson disease: the Atherosclerosis Risk in Communities study. Annals Neurol 77(5):877–883. doi:10.1002/ana.24393 CrossRef Alonso A, Huang X, Mosley TH, Heiss G, Chen H (2015) Heart rate variability and the risk of Parkinson disease: the Atherosclerosis Risk in Communities study. Annals Neurol 77(5):877–883. doi:10.​1002/​ana.​24393 CrossRef
29.
go back to reference Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119(6):689–702. doi:10.1007/s00401-010-0664-3 CrossRefPubMedPubMedCentral Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119(6):689–702. doi:10.​1007/​s00401-010-0664-3 CrossRefPubMedPubMedCentral
33.
go back to reference Eadie MJ (1963) The Pathology of Certain Medullary Nuclei in Parkinsonism. Brain J Neurol 86:781–792CrossRef Eadie MJ (1963) The Pathology of Certain Medullary Nuclei in Parkinsonism. Brain J Neurol 86:781–792CrossRef
Metadata
Title
Cardiac parasympathetic dysfunction in the early phase of Parkinson’s disease
Authors
Masashi Suzuki
Tomohiko Nakamura
Masaaki Hirayama
Miki Ueda
Masahisa Katsuno
Gen Sobue
Publication date
01-02-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 2/2017
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-016-8348-0

Other articles of this Issue 2/2017

Journal of Neurology 2/2017 Go to the issue